登录 注册 会员服务 联系我们

Cisplatin-stimulated macrophages promote ovarian cancer migration via the CCL20-CCR6 axis

  • Published:2020-03 Issue: Volume:472 Page:59-69
  • ISSN:0304-3835
  • Container-title:Cancer Letters
  • language:en
  • Short-container-title:Cancer Letters

Author:

Liu Wan,Wang Wenjing,Wang Xinran,Xu Cong,Zhang Ning,Di Wen

Funder

National Key Research and Development Program

863

National Natural Science Foundation of China

Science and Technology Commission of Shanghai Municipality

Shanghai Municipal Commission of Health and Family Planning

Shanghai Hospital Development Center

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference62 articles.

1. Cancer statistics, 2017;Siegel;CA A Cancer J. Clin.,2017

2. Relative frequency of primary ovarian neoplasms: a 10-year review;Koonings;Obstet. Gynecol.,1989

3. The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin;Seidman;Int. J. Gynecol. Pathol. : Off. J. Int. Soc. Gynecol. Pathol.,2004

4. The management of recurrent ovarian cancer;Bukowski;Semin. Oncol.,2007

5. Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group;Miller;J. Clin. Oncol. : Off. J. Am. Soc. Clin. Oncol.,2009
同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3